Blood Clotting Biotech Hemab Hauls In $135M to Drug Rare Bleeding Disorders
Clotting disorders can be treated by infusing patients with clotting proteins they lack, or with drugs that replace the function of these proteins. Gene therapies may soon become another option. Hemophilia A and B…
Continue Reading
